Navigation Links
Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)
Date:4/2/2008

ulin. Check with your healthcare provider before you start an exercise program because your dose may need to be changed.

For full prescribing information, please visit http://www.Apidra.com.

IMPORTANT SAFETY INFORMATION FOR LANTUS(R)

Prescription Lantus(R) is for adults with type 2 diabetes or adults and children (6 years and older) with type 1 diabetes who require long-acting insulin for the control of high blood sugar.

DO NOT DILUTE OR MIX LANTUS(R) WITH ANY OTHER INSULIN OR SOLUTION. It will not work as intended, and you may lose blood sugar control, which could be serious. Do not change your insulin without talking with your doctor. The syringe must not contain any other medication or residue. You should not use Lantus(R) if you are allergic to insulin. Lantus(R) is a long-acting insulin you inject just once a day, at the same time each day. You must test your blood sugar levels while using an insulin such as Lantus(R).

The most common side effect of insulin, including Lantus(R), is hypoglycemia, which may be serious. Other possible side effects may include injection site reactions, including changes in fat tissue at the injection site, and allergic reactions, including itching and rash. In rare cases, some allergic reactions may be life threatening. Tell your doctor about other medicines and supplements you are taking because they can change the way insulin works.

For full prescribing information, please visit http://www.Lantus.com.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone.

Sanofi-aventis is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY).

U.S. Contacts:

Carrie Melia

Carrie.melia@sanofi-aventis.com

908-981-6486

US.GLU.0
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
2. New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
3. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
4. New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients
5. Reduced Lung Capacity Accelerates With Diabetes
6. Revised: Challenging the Norm May Lead to New Therapy for Type 2 Diabetes
7. Challenging the Norm May Lead to New Therapy for Type 2 Diabetes
8. Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
9. Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
10. UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation
11. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Cumberland Pharmaceuticals Inc. ( CPIX) ... results for a patient preference study evaluating Kristalose ... laxative packaged as a crystalline powder, compared to ... the only prescription-strength laxative available in pre-measured powder ... a recent diagnosis of chronic constipation were administered ...
(Date:12/15/2009)... LAKE ZURICH, Ill., Dec. 15 Fenwal ... improving blood collection, separation, safety and availability, announced ... has granted Fenwal approval to market InterSol ® ... InterSol ® solution is a specialized product ... donated platelets, a vital blood component used to ...
(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Analysis and Market Forecasts to 2015 ... ,, Systemic Lupus Erythematosus - Drug ... 2015 ,, Summary ,, ...
Breaking Medicine Technology:Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8Grand Opening 3A An Exercise Program for People Who Just Love To Dance 56635 1Grand Opening 3A An Exercise Program for People Who Just Love To Dance 56635 2AUDIO from Medialink and Pfizer 3A September is Pain Awareness Month 56632 1Announcing Sustainability in Packaging 2010 3A Strategies to make sustainability sustainable 13946 1Announcing Sustainability in Packaging 2010 3A Strategies to make sustainability sustainable 13946 2Announcing Sustainability in Packaging 2010 3A Strategies to make sustainability sustainable 13946 3
(Date:12/15/2009)... High levels of leptin associated with lower dementia risk, ... High blood levels of leptin, a hormone that regulates ... , "Hopefully, in 10 or 15 years this may ... reduce the risk of Alzheimer,s disease," said senior study ... at Boston University School of Medicine. "Or it may ...
(Date:12/15/2009)... but not delivered ,, WASHINGTON, Dec. 15 ... to ensure that healthcare reform does not override ... insurance companies in 37 states. ,, Prostate cancer ... the population and individuals who are identifiable as ... who have a family history of prostate cancer. ...
(Date:12/15/2009)... WHITE PLAINS, N.Y., Dec. 15 Team ... (LLS) groundbreaking charity sports training program, ... billion to support blood cancer research and patient ... has been the pre-eminent charity endurance sports training ... a marathon, half marathon, triathlon, 100-mile century cycle ...
(Date:12/15/2009)... 15 North American application activity for ... year-over-year, according to the MIB Life Index(SM) ... over the past three months have lifted year-to-date ... -1.6%, to flat at November,s close, -0.1%. ... in the benefits available from life insurance," says ...
(Date:12/15/2009)... can help older adults delay or reverse declining ... researchers at the Johns Hopkins Bloomberg School of ... the researchers found that seniors participating in a ... regions that support cognitive abilities important to planning ... the first of its kind to demonstrate that ...
Breaking Medicine News(10 mins):Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:For older adults, participating in social service activities can improve brain functions 2
... 4 CryoCor, Inc. (Nasdaq:,CRYO), a medical device ... today the publication of a European study of ... purpose of the study was to evaluate the ... fibrillation and the effectiveness of an ablation,strategy focused ...
... study, 10 minutes of counseling helped people cut down on ... Even a little counseling on the dangers of alcohol abuse ... drinkers cut back by at least three drinks a week, ... a standard alcohol-use screening and counseling tool, then applied it ...
... 2 Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ... has received final approval from the,United States (U.S.) ... Drug Application (ANDA) for Ipratropium Bromide and Albuterol ... Watson,s Ipratropium Bromide and Albuterol Sulfate product ...
... Jan. 2 Barr Pharmaceuticals,Inc. (NYSE: BRL ... has received final approval from the U.S. Food ... Roche Laboratories Inc.,s KYTRIL(R),(granisetron hydrochloride) Tablets, 1mg (eq ... following the expiration of Roche,s patent on,December 28, ...
... KANSAS CITY, Mo. An estimated 750,000 hospitalized ... less than 30 percent of those leave the hospital ... the Jan. 3 issue of the New England Journal ... life-saving electrical shock (defibrillation) among hospitalized patients experiencing a ...
... free unique support channels, OWINGS MILLS, Md., Jan. ... that the Company is offering a special deal for,clients ... is,offering Pure Weight Loss clients $55 Off a Purchase ... http://www.puremedifast.com or by calling 800-692-1791., Medifast is ...
Other Medicine News:Health News:CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation 2Health News:CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation 3Health News:Brief Chat With ER Docs Can Curb Problem Drinking 2Health News:Watson Receives FDA Approval for Generic DuoNeb(R) 2Health News:Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base) 2Health News:Barr Receives Approval for Generic KYTRIL(R) Tablets, 1mg (Base) 3Health News:For hospital patients, defibrillation delays mean lower survival 2Health News:Medifast Offers Stranded Pure Weight Loss Clients Unique Options 2Health News:Medifast Offers Stranded Pure Weight Loss Clients Unique Options 3
... chrome plated brass. Lamp supplied in ... coded systems worldwide are in general ... design give some variation in the ... well with other systems using locking ...
... Greenspec Laryngoscopes are a high quality fiberoptic ... bringing greater standardization to fiberoptic laryngoscopes. The ... and indicates it's ability to interconnect with ... light offers a cool, bright and focused ...
... vocal cords in even the most difficult cases. ... standard laryngoscope, Viewmax® does not require special training. ... to allow intubation whether you are faced with ... has a patented lens system that refracts the ...
... a unique fiberoptic laryngoscope blade that can ... sometimes needed during difficult intubations. The articulating ... blade to be raised by squeezing a ... operation produces a more complete exposure of ...
Medicine Products: